Department of Ophthalmology, Xi'an No. 3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, 710018, China.
Department of Hemodialysis, Xi'an No. 3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, 710018, China.
BMC Ophthalmol. 2024 Aug 9;24(1):334. doi: 10.1186/s12886-024-03612-5.
Diabetes can cause chronic microvascular complications such as diabetic retinopathy (DR) and diabetic nephropathy (DN). DR and DN can lead to or exacerbate diabetic macular edema (DME). Hemodialysis (HD) is the main treatment method for patients with end-stage kidney disease (ESKD) secondary to DN.
The aim of this prospective cohort study was to determine the immediate effect of single HD session on retinal and choroidal thickness in DR patients with ESKD and the features of DR and the prevalence of DME in these patients who have received long-term HD.
Eighty-five eyes of 44 DR patients with ESKD who underwent long-term HD were examined by swept-source optical coherence tomography angiography (SS-OCTA). Based on OCTA images, the characteristics of DR and the prevalence of DME in these patients were analyzed. Changes in central retinal thickness (CRT), central retinal volume (CRV), subfoveal choroidal thickness (SFCT) and subfoveal choroidal volume (SFCV) within 30 min before and after single HD session were compared. CRT, CRV, SFCT and SFCV were compared before single HD session and before the next single HD session.
There was no significant difference in the average CRT (251.69 ± 39.21 μm vs. 251.46 ± 39.38 μm, P = 0.286) or CRV (0.15 ± 0.62 μm vs. 0.15 ± 0.63 μm, P = 0.324) between before and after single HD session. After single HD session, SFCT (243.11 ± 77.15 μm vs. 219.20 ± 72.84 μm, P < 0.001) and SFCV (0.15 ± 0.10 μm vs. 0.13 ± 0.90 μm, P < 0.001) significantly decreased. There was no statistically significant difference in CRT (251.69 ± 39.21 μm vs. 251.11 ± 38.47 μm, P = 0.206), CRV (0.15 ± 0.62 μm vs. 0.15 ± 0.61 μm, P = 0.154), SFCT (243.11 ± 77.15 μm vs. 245.41 ± 76.23 μm, P = 0.108), or SFCV (0.15 ± 0.10 μm vs. 0.16 ± 0.10 μm, P = 0.174) before HD and before the next single HD session. On en face OCTA images, eighty-five eyes (100%) had retinal nonperfusion areas, foveal avascular zone (FAZ) enlargement, and abnormal retinal microvasculature. Based on cross-sectional OCTA images, retinal neovascularization (RNV) was confirmed in 42 eyes (49.41%), and intraretinal microvascular abnormalities (IRMAs) were detected in 85 eyes (100%). Seventeen eyes (20%) still had DME, all of which were cystoid macular edema (CME). Among eyes with DME, the epiretinal membrane (ERM) was present in 7 eyes (8.24%).
For DR patients with ESKD who have undergone long-term HD, the choroidal thickness still changes significantly before and after single HD session, which may be related to short-term effects such as reduced blood volume and plasma osmotic pressure caused by single HD session. Although macular features seem to have stabilized in DR patients undergoing long-term dialysis, the DR of patients with ESKD should still be given attention.
糖尿病会导致慢性微血管并发症,如糖尿病视网膜病变(DR)和糖尿病肾病(DN)。DR 和 DN 可导致或加重糖尿病性黄斑水肿(DME)。血液透析(HD)是 DN 引起的终末期肾病(ESKD)患者的主要治疗方法。
本前瞻性队列研究旨在确定单次 HD 治疗对 ESKD 合并 DR 患者视网膜和脉络膜厚度的即刻影响,以及这些长期接受 HD 治疗的患者的 DR 特征和 DME 的患病率。
对 44 例接受长期 HD 的 DR 合并 ESKD 患者的 85 只眼进行扫频源光学相干断层扫描血管造影(SS-OCTA)检查。根据 OCTA 图像,分析这些患者的 DR 特征和 DME 的患病率。比较单次 HD 治疗前后 30 分钟内中央视网膜厚度(CRT)、中央视网膜容积(CRV)、中心凹下脉络膜厚度(SFCT)和中心凹下脉络膜容积(SFCV)的变化。比较单次 HD 治疗前和下一次单次 HD 治疗前的 CRT、CRV、SFCT 和 SFCV。
单次 HD 治疗前后平均 CRT(251.69±39.21 μm 比 251.46±39.38 μm,P=0.286)或 CRV(0.15±0.62 μm 比 0.15±0.63 μm,P=0.324)差异无统计学意义。单次 HD 治疗后 SFCT(243.11±77.15 μm 比 219.20±72.84 μm,P<0.001)和 SFCV(0.15±0.10 μm 比 0.13±0.90 μm,P<0.001)明显降低。CRT(251.69±39.21 μm 比 251.11±38.47 μm,P=0.206)、CRV(0.15±0.62 μm 比 0.15±0.61 μm,P=0.154)、SFCT(243.11±77.15 μm 比 245.41±76.23 μm,P=0.108)和 SFCV(0.15±0.10 μm 比 0.16±0.10 μm,P=0.174)在 HD 前和下一次单次 HD 治疗前无统计学差异。在 en face OCTA 图像上,85 只眼(100%)均有视网膜无灌注区、中心凹无血管区(FAZ)扩大和视网膜微血管异常。根据横断面 OCTA 图像,42 只眼(49.41%)证实存在视网膜新生血管(RNV),85 只眼(100%)存在视网膜内微血管异常(IRMA)。17 只眼(20%)仍有 DME,均为囊样黄斑水肿(CME)。在有 DME 的眼中,7 只眼(8.24%)有视网膜前膜(ERM)。
对于长期接受 HD 的 ESKD 合并 DR 患者,单次 HD 治疗前后脉络膜厚度仍有明显变化,这可能与单次 HD 治疗引起的血容量和血浆渗透压短期降低等因素有关。尽管长期透析的 DR 患者黄斑特征似乎已经稳定,但仍应关注 ESKD 患者的 DR。